DNA-based molecular computation allows for the simultaneous detection of multiple types of biomarker, as shown for the accurate identification of prostate cancer in serum samples on the basis of specific RNAs, proteins and small molecules.
This is a preview of subscription content, log in via an institution to check access.
References
Vargas, A. J. et al. Nat. Rev. Cancer 16, 525–537 (2016).
Collins, F. S. et al. N. Engl. J. Med. 372, 793–795 (2015).
Blanc, T. et al. Nat. Methods 17, 1100–1102 (2020).
Tarazona, S. et al. Nat. Comput. Sci. 1, 395–402 (2021).
Kieffer, C. et al. Adv. Biol. 7, e2200203 (2023).
Zhang, D. Y. et al. Nat. Chem. 3, 103–113 (2011).
Lopez, R. et al. Nat. Chem. 10, 746–754 (2018).
Zhang, C. et al. Nat. Nanotechnol. 15, 709–715 (2020).
Yin, F. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-023-01348-9 (2023).
Reischl, U. & Kochanowski, B. Mol. Biotechnol. 3, 55–71 (1995).
Tanaka, G. et al. Neural Netw. 115, 100–123 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Yu, L., Yan, H. DNA-based computation for multiple biomarkers. Nat. Biomed. Eng 7, 1535–1536 (2023). https://doi.org/10.1038/s41551-023-01161-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-023-01161-8
- Springer Nature Limited